Suchergebnisse - "ALK protein, human"

PubPharm (3.256)

1

A pragmatic guide for management of adverse events associated with lorlatinib

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Liu, G. | Mazieres, J. | Stratmann, J. | +7

2

Peripheral T-cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK-negative

enthalten in: British journal of haematology | 2024

von Ganapathi, K. | Nicolae, A. | Egan, C. | +7

3

Localised ALK-positive histiocytosis in lung with EML4::ALK fusion

enthalten in: Pathology | 2024

von Zou, L. | Lu, T. | Li, M. | +4

4

Identification of a novel ALK inhibitor-sensitive PRKCE-ALK gene fusion in lung adenocarcinoma

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Wang, L. | Li, L. | Zhou, X. | +1

5

Variant ALK-fusion positive anaplastic large cell lymphoma (ALCL) : A population-based paediatric study of the NHL-BFM study group

enthalten in: British journal of haematology | 2024

von Luedersen, J. | Stadt, U. | Richter, J. | +15

6

Concurrent inhibition of ALK and SRC kinases disrupts the ALK lung tumor cell proteome

enthalten in: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy | 2024

von Diaz-Jimenez, A. | Ramos, M. | Helm, B. | +7

7

Anaplastic large cell lymphoma with ALK::ATIC fusion mimicking a histiocytic sarcoma debuting as an anterior thoracic soft tissue tumor with exceptional clinicopathological, morphological and molecular features

enthalten in: Thoracic cancer | 2024

von García-Muñiz, J. | Vilches-Cisneros, N. | Flores-Gutiérrez, J. | +1

8

Novel therapeutic strategies for rare mutations in non-small cell lung cancer

enthalten in: Scientific reports | 2024

von Gou, Q. | Gou, Q. | Gan, X. | +1

9

Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer

enthalten in: Nature communications | 2024

von Haderk, F. | Chou, Y. | Cech, L. | +32

10

Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations

enthalten in: Cancer research | 2024

von Park, S. | Ju, S. | Goh, S. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[326]